Search - tctmd.com

Displaying 421 - 440 of 722

Sort: Relevancy | Date

Presentation TCT 2015

Update on Boston Scientifics REINFORCE

Presenter: Farrell O. Mendelsohn, William B. White, Michael A. Weber

October 11, 2015

Presentation TCT 2015

Update on Medtronics Spyral Global

Presenter: Farrell O. Mendelsohn, William B. White, Michael Böhm

October 11, 2015

Presentation TCT 2015

Considerations and Recommendations for Future Clinical Trials in Device-Based Hypertension Treatments

Presenter: Farrell O. Mendelsohn, William B. White

October 11, 2015

Presentation TCT 2015

Putting It All Together: Procedural Recommendations in 2015

Presenter: Juan F. Granada, Michael Joner, Krishna J. Rocha-Singh

October 11, 2015

Presentation TCT 2015

Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation

Presenter: Juan F. Granada, Michael Joner, Elazer R. Edelman

October 11, 2015

Presentation TCT 2015

Time to Revise Treatment Recommendations: Go Distal and Into the Branches

Presenter: Juan F. Granada, Michael Joner, Justin E. Davies

October 11, 2015

Presentation TCT 2015

Lesion Characteristics From the Different Devices: Do They Differ?

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Procedural Parameters for Successful Renal Denervation: Anything on the Horizon?

Presenter: Juan F. Granada, Michael Joner, Michael Böhm

October 11, 2015

Presentation TCT 2015

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Presenter: Juan F. Granada, Michael Joner

October 11, 2015

Presentation TCT 2015

Unresolved Issues and the Path Moving Forward

Presenter: Ajay J. Kirtane, Felix Mahfoud

October 11, 2015

Presentation TCT 2015

Myths as to Why SYMPLICITY HTN-3 Failed

Presenter: Ajay J. Kirtane, Felix Mahfoud, Darrel P. Francis

October 11, 2015

Presentation TCT 2015

Device-Based Therapies for Hypertension Treatment: Procedural Aspects

Presenter: Ajay J. Kirtane, Felix Mahfoud, Farrell O. Mendelsohn

October 11, 2015

Presentation TCT 2015

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

Presenter: Ajay J. Kirtane, Felix Mahfoud, Michael A. Weber

October 11, 2015

News Conference News TCT 2015

SYMPLICITY HTN-3 Results Continue to Spur Discussion

October 11, 2015

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

Presentation CCVVC 2015

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Presenter: Mark Wholey

June 17, 2015

News Daily News

Event Rates Often Overestimated in Cardiovascular Trials

Yael L. Maxwell

June 10, 2015

News Industry News

Medtronic Announces FDA Clearance and U.S. Launch of the Euphora(TM) Semicompliant Coronary Balloon

May 05, 2015

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Daily News

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

February 03, 2015

Advertisement

Update on Boston Scientifics REINFORCE

Update on Medtronics Spyral Global

Considerations and Recommendations for Future Clinical Trials in Device-Based Hypertension Treatments

Putting It All Together: Procedural Recommendations in 2015

Influence of Arterial Microanatomy on Response to Renal Artery Catheter Energy Denervation

Time to Revise Treatment Recommendations: Go Distal and Into the Branches

Lesion Characteristics From the Different Devices: Do They Differ?

Procedural Parameters for Successful Renal Denervation: Anything on the Horizon?

Nerve Distribution Along the Renal Arteries: From the Branches to the Ostium

Unresolved Issues and the Path Moving Forward

Myths as to Why SYMPLICITY HTN-3 Failed

Device-Based Therapies for Hypertension Treatment: Procedural Aspects

Uncontrolled Hypertension: Prevalence, Prognosis, and Treatment

SYMPLICITY HTN-3 Results Continue to Spur Discussion

Boston Scientific Announces Scheduled Presentations At TCT 2015

New Concepts in Endovascular Treatment: Present And Future Status Of Renal Denervation After The Negative SIMPLICITY Trial

Event Rates Often Overestimated in Cardiovascular Trials

Medtronic Announces FDA Clearance and U.S. Launch of the Euphora(TM) Semicompliant Coronary Balloon

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

New Percutaneous Device Reduces Resistant Hypertension in Small Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content